XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 57,765 $ 34,522
Marketable securities 232,592 240,736
Accounts receivable, net 22,809 24,790
Prepaid expenses 10,021 14,520
Other current assets 23,496 20,403
Total current assets 346,683 334,971
Marketable securities 36,943 38,871
Accounts receivable 464 701
Property and equipment, net 123,969 132,103
Operating lease right-of-use assets 56,344 60,487
Restricted cash 2,030 2,030
Other assets 2,946 4,807
Total assets 569,379 573,970
Current liabilities    
Accounts payable 16,362 22,786
Accrued expenses and other current liabilities 42,488 49,703
Deferred revenue 21 148
Operating lease liabilities 7,302 7,068
Liability related to sale of future royalties 32,100 50,567
Total current liabilities 98,273 130,272
Operating lease liabilities 78,234 82,222
Liability related to sale of future royalties 41,079 43,485
Other liabilities 3,526 6,249
Total liabilities 221,112 262,228
Stockholders’ equity    
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at June 30, 2024 and December 31, 2023
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2024 and December 31, 2023; 49,317 and 44,046 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 5 4
Additional paid-in capital 1,171,894 1,021,214
Accumulated other comprehensive loss (2,266) (4,429)
Accumulated deficit (821,366) (705,047)
Total stockholders’ equity 348,267 311,742
Total liabilities and stockholders’ equity $ 569,379 $ 573,970